# Febuxostat

NDC: 27808-207
Generic name: febuxostat
Labeler / Manufacturer: Tris Pharma Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20200928

FDA application: ANDA210292

## Active ingredients

- FEBUXOSTAT: 80 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"27808-207"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=27808-207
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=d3b18653-9487-4a78-82c0-80ee024b8ef6